arrow
J

Julie Navez

erasme university hospital
H指数:17
被引数:771

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy

新辅助FOLFIRINOX治疗后序贯高剂量立体定向体部放疗对胰腺导管腺癌有利的组织-分子重塑

2026-01-050
OAAI
Management of refractory chyle leak after pancreatic surgery: Results from a French national survey on practices and a multicentric study on therapeutic lymphangiography

难治性乳糜漏的术后管理:法国全国实践调查及多中心治疗性淋巴管造影研究结果

Surgery
IF2.7
2025-07-160
PRE
ASO Author Reflections: Complete Pathological Response after Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinomas-Curative Surgery in Cured Patients?
2025-02-010
PRE
ASO Visual Abstract: Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for Pancreatic AdenOcarciNOma in the FOFLIRINOX Era: The Multicenter TONO Study
2025-01-290
PRE
Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter TONO Study

Fofirinox时代胰腺腺癌新辅助治疗后完全病理缓解的预后: 多中心TONO研究

2025-01-081
PRE
Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel plus /- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial

mFOLFIRINOX或吉西他滨/Nab紫杉醇加/-等毒性高剂量立体定向放射治疗 (ihd-sbrt) 的术前治疗可切除的胰腺腺癌 (STEREOPAC试验): 一项随机对照多中心II期试验的研究方案

2023-09-214
OAAI
Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
2021-10-1914
OAAI